You are here

Antibacterial Drugs Market to Touch US$51,447.6 Million by 2025; Increasing Resistance to Bacteria to Combination of Multidrug Propels the Industry Growth - TMR

ALBANY, New York, July 8, 2019 /PRNewswire/ -- According to a research by TMR, the global antibacterial drugs market is foreseen to expand at a slow CAGR of 1.5% within the forecast period from 2017 to 2025. In 2016, the market was valued to be around US$45,325.0 mn. This figure is estimated to reach around worth of US$51,447.6 mn by 2025-end.

On the basis of routes of administration, the global antibacterial drugs market is classified as enteral, parenteral and others. Among these, in 2016, the enteral segment is foreseen to experience the highest share of the global antibacterial drugs market and is likely to expand at a remarkable rate in the forthcoming years. Geographically, North America region is leading the global market and is anticipated to flourish at a substantial rate in the upcoming years, owing to increasing infection rate, treatment, and diagnosis rate.

Get PDF Brochure for Research Insights at

Rising Investments by Players to Project Opportunities in Spanish Market

Antibacterial drugs are the substances which are extracted from bacterium to treat bacterial infections. The global antibacterial drugs market is fuelled by the increasingly developing demand regarding new range of agents and antibacterial resistance. The antibacterial drugs market is probably going to come across two difficulties, for example, lack of return on investment and expiry of the licensed drugs. The global antibacterial drugs market additionally displays a market infiltration and significant pipeline of nonexclusive drugs. The market is likely to provide several lucrative opportunities in Spanish market through rising investments by key players.

Request a PDF Sample -

Increasing cases of contagious ailments globally and developing resistance over bacteria to multidrug blends are among the important components supporting the demand regarding the antibacterial drugs. Accessibility of drugs to satiate surging demand for effective and reasonable antibacterial drugs is propelling development of the global antibacterial drugs market. Moreover, increase in elderly population all over the developed and developing nations is helping growth of the global antibacterial drugs market over span of coming years.

Request a Custom Report at

Nevertheless, unregulated drugs prescription that may cause some common side-effects are significantly obstructing the development of the global antibacterial drugs market. Moreover, genetic changes is another major hindering point pulling back the development in the global antibacterial drugs market. All things considered, advancement in technology through innovative drug formulation are anticipated to help popularity of drugs and make potential development scope for the global antibacterial drugs market.

Request For Discount On This Report -

Government Initiatives for Commercialization of Treatments to Propel Growth of Antibacterial Drugs Market

Moreover, developing activities by various governments and key players for the commercialization of treatments are foreseen to reinforce the development of the market. These activities have resulted in innovation in enteral routes to administer drugs and are accessible all over the developed and developing regions, which are foreseen to surge the demand in global antibacterial drugs market.

Read Press Release -

The global antibacterial drugs market is expected to witness a significant development in the span of coming years, says a report by Transparency Market Research (TMR). The competitive scenario is likely to be strong owing to the emergence of well-established players across the globe. Major players operating in the global antibacterial drugs market are Allergan, Plc., Novartis AG, Bristol Myers Squibb Company acquired by AstraZeneca, Merck & Co., Inc., Johnson and Johnson, GlaxoSmithKline Plc. (GSK), and Sanofi. To cope up with the cutthroat competition among the new and old players, they firms have taken up strategies such as mergers and acquisitions.

This analysis is based on a recent market research report by Transparency Market Research, titled, "Antibacterial Drugs Market (Drug Class - B - lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, and Phenicols; Routes of Administration - Enteral and Parenteral; Distribution Channel - Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025."

Popular Research Reports by TMR:

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Research Blog: